Jantana Houngsaitong

Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study

Piyatip Khuntayaporn, Pohnvipa Kanathum, Jantana Houngsaitong et al. · Annals of Clinical Microbiology and Antimicrobials · 2021 · 76 citations · Full text

Optimizing intravenous fosfomycin dosing in combination with carbapenems for treatment of Pseudomonas aeruginosa infections in critically ill patients based on pharmacokinetic/pharmacodynamic (PK/PD) simulation

Orarik Asuphon, Preecha Montakantikul, Jantana Houngsaitong et al. · International Journal of Infectious Diseases · 2016 · 58 citations · Full text

Prevalence of OXA-Type β-Lactamase Genes among Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates in Thailand

Krit Thirapanmethee, Thayapa Srisiri-a-nun, Jantana Houngsaitong et al. · Antibiotics · 2020 · 34 citations · Full text

In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant Acinetobacter baumannii Using the Broth Microdilution Checkerboard and Time-Kill Methods

Vipavee Rodjun, Jantana Houngsaitong, Preecha Montakantikul et al. · Antibiotics · 2020 · 12 citations · Full text

Pharmacokinetic/Pharmacodynamic (PK/PD) Simulation for Dosage Optimization of Colistin Against Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Escherichia coli

Kamonchanok Jitaree, Korbtham Sathirakul, Jantana Houngsaitong et al. · Antibiotics · 2019 · 10 citations · Full text